Plasma brain natriuretic peptide-guided therapy not yet justified.

1. Iakovow I, Schmidt T, Bonizzoni E, et al. Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126–30. 2. Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus and paclitaxel-eluting stents. Circulation 2006;113; 1108 –13. 3. Alfonso F, Suarez A, Angiolillo DJ, et al. Findings of intravascular ultrasound during acute stent thrombosis. Heart 2004;90:1455–9. 4. Uren NG, Scharzacher SP, Metz JA. Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry. Eur Heart J 2002;23: 124–32. 5. Cheneau E, Leborgne L, Mintz GS, et al. Predictors of subacute thrombosis: results of a systematic intravascular ultrasound study. Circulation 2003;108:2–5. 6. Degertekin M, Serruys PW, Tanabe K, et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis. Circulation 2003;108:2747–50. 7. Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug-eluting stent implantation. An intravascular ultrasound analysis with long-term follow-up. Circulation 2006;113;414–9. 8. Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after drugeluting stent implantation. An intravascular ultrasound study. J Am Coll Cardiol 2005;45:995–8. 9. Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007;115:2426–34.